FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004094927> ?p ?o ?g. }

• W2004094927 endingPage "381" @default.
• W2004094927 startingPage "375" @default.
• W2004094927 abstract "Epstein–Barr virus (EBV), which infects B cells, T cells, and natural killer (NK) cells, is associated with multiple lymphoid malignancies. Recently, histone deacetylase (HDAC) inhibitors have been reported to have anticancer effects against various tumor cells. In the present study, we evaluated the killing effect of valproic acid (VPA), which acts as an HDAC inhibitor, on EBV‐positive and ‐negative T and NK lymphoma cells. Treatment of multiple T and NK cell lines (SNT13, SNT16, Jurkat, SNK6, KAI3 and KHYG1) with 0.1‐5 mM of VPA inhibited HDAC, increased acetylated histone levels and reduced cell viability. No significant differences were seen between EBV‐positive and ‐negative cell lines. Although VPA induced apoptosis in some T and NK cell lines (SNT16, Jurkat and KHYG1) and cell cycle arrest, it did not induce lytic infection in EBV‐positive T or NK cell lines. Because the killing effect of VPA was modest (1 mM VPA reduced cell viability by between 22% and 56%), we tested the effects of the combination of 1 mM of VPA and 0.01 μM of the proteasome inhibitor bortezomib. The combined treated of cells with VPA and bortezomib had an additive killing effect. Finally, we administered VPA to peripheral blood mononuclear cells from three patients with EBV‐associated T or NK lymphoproliferative diseases. In these studies, VPA had a greater killing effect against EBV‐infected cells than uninfected cells, and the effect was increased when VPA was combined with bortezomib. These results indicate that VPA has antitumor effects on T and NK lymphoma cells and that VPA and bortezomib may have synergistic effects, irrespective of the presence of EBV. ( Cancer Sci 2012; 103: 375–381)" @default.
• W2004094927 created "2016-06-24" @default.
• W2004094927 creator A5013301564 @default.
• W2004094927 creator A5036353568 @default.
• W2004094927 creator A5038751838 @default.
• W2004094927 creator A5040074995 @default.
• W2004094927 creator A5052758613 @default.
• W2004094927 creator A5056456386 @default.
• W2004094927 creator A5077479682 @default.
• W2004094927 creator A5078340798 @default.
• W2004094927 date "2011-11-22" @default.
• W2004094927 modified "2023-10-18" @default.
• W2004094927 title "Antitumor activities of valproic acid on Epstein-Barr virus-associated T and natural killer lymphoma cells" @default.
• W2004094927 cites W1967018540 @default.
• W2004094927 cites W1971168916 @default.
• W2004094927 cites W1999625162 @default.
• W2004094927 cites W2010629311 @default.
• W2004094927 cites W2010833137 @default.
• W2004094927 cites W2026548207 @default.
• W2004094927 cites W2028624655 @default.
• W2004094927 cites W2033447452 @default.
• W2004094927 cites W2033938104 @default.
• W2004094927 cites W2036386987 @default.
• W2004094927 cites W2040626805 @default.
• W2004094927 cites W2043946207 @default.
• W2004094927 cites W2051821583 @default.
• W2004094927 cites W2054341505 @default.
• W2004094927 cites W2058350611 @default.
• W2004094927 cites W2071380029 @default.
• W2004094927 cites W2073631928 @default.
• W2004094927 cites W2076603205 @default.
• W2004094927 cites W2083329634 @default.
• W2004094927 cites W2083376492 @default.
• W2004094927 cites W2095361625 @default.
• W2004094927 cites W2097856894 @default.
• W2004094927 cites W2103695905 @default.
• W2004094927 cites W2104223678 @default.
• W2004094927 cites W2104805076 @default.
• W2004094927 cites W2106206678 @default.
• W2004094927 cites W2112133358 @default.
• W2004094927 cites W2118745945 @default.
• W2004094927 cites W2123961406 @default.
• W2004094927 cites W2131098924 @default.
• W2004094927 cites W2139792658 @default.
• W2004094927 cites W2154227505 @default.
• W2004094927 cites W2158877141 @default.
• W2004094927 cites W2159517806 @default.
• W2004094927 cites W2159580351 @default.
• W2004094927 cites W2522939951 @default.
• W2004094927 doi "https://doi.org/10.1111/j.1349-7006.2011.02127.x" @default.
• W2004094927 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22017376" @default.
• W2004094927 hasPublicationYear "2011" @default.
• W2004094927 type Work @default.
• W2004094927 sameAs 2004094927 @default.
• W2004094927 citedByCount "24" @default.
• W2004094927 countsByYear W20040949272012 @default.
• W2004094927 countsByYear W20040949272013 @default.
• W2004094927 countsByYear W20040949272014 @default.
• W2004094927 countsByYear W20040949272015 @default.
• W2004094927 countsByYear W20040949272016 @default.
• W2004094927 countsByYear W20040949272018 @default.
• W2004094927 countsByYear W20040949272019 @default.
• W2004094927 countsByYear W20040949272021 @default.
• W2004094927 countsByYear W20040949272023 @default.
• W2004094927 crossrefType "journal-article" @default.
• W2004094927 hasAuthorship W2004094927A5013301564 @default.
• W2004094927 hasAuthorship W2004094927A5036353568 @default.
• W2004094927 hasAuthorship W2004094927A5038751838 @default.
• W2004094927 hasAuthorship W2004094927A5040074995 @default.
• W2004094927 hasAuthorship W2004094927A5052758613 @default.
• W2004094927 hasAuthorship W2004094927A5056456386 @default.
• W2004094927 hasAuthorship W2004094927A5077479682 @default.
• W2004094927 hasAuthorship W2004094927A5078340798 @default.
• W2004094927 hasBestOaLocation W20040949271 @default.
• W2004094927 hasConcept C104317684 @default.
• W2004094927 hasConcept C179464577 @default.
• W2004094927 hasConcept C182615771 @default.
• W2004094927 hasConcept C190283241 @default.
• W2004094927 hasConcept C203014093 @default.
• W2004094927 hasConcept C2522874641 @default.
• W2004094927 hasConcept C2776090121 @default.
• W2004094927 hasConcept C2776202225 @default.
• W2004094927 hasConcept C2776364478 @default.
• W2004094927 hasConcept C2777478702 @default.
• W2004094927 hasConcept C2778305200 @default.
• W2004094927 hasConcept C2778367456 @default.
• W2004094927 hasConcept C2779338263 @default.
• W2004094927 hasConcept C2781375147 @default.
• W2004094927 hasConcept C502942594 @default.
• W2004094927 hasConcept C53227056 @default.
• W2004094927 hasConcept C54355233 @default.
• W2004094927 hasConcept C55493867 @default.
• W2004094927 hasConcept C64927066 @default.
• W2004094927 hasConcept C81885089 @default.
• W2004094927 hasConcept C86803240 @default.
• W2004094927 hasConcept C8891405 @default.
• W2004094927 hasConceptScore W2004094927C104317684 @default.
• W2004094927 hasConceptScore W2004094927C179464577 @default.

• next